Literature DB >> 6627601

Prevention of adriamycin toxicity.

A R Banks, T Jones, T H Koch, R D Friedman, N R Bachur.   

Abstract

Mice treated with lethal doses of adriamycin (A1) (IP) are rescued with a single IP dose of 3,5,5-trimethyl-2-morpholinon-3-yl radical dimer (TM3). The in vivo rescue is assumed to be analogous to the in vitro reaction of TM3 with A1 that produces the non-toxic 7-deoxy-adriamycinone (7dAone). TM3 prevents death if given within 60 min following A1 administration. Control A1-treated mice died by 8 days (median survival time) whereas TM3 rescued A1-treated mice had a median survival time of greater than 60 days.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6627601     DOI: 10.1007/bf00254252

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

1.  Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation.

Authors:  N R Bachur; S L Gordon; M V Gee
Journal:  Mol Pharmacol       Date:  1977-09       Impact factor: 4.436

2.  Adriamycin: amelioration of toxicity by alpha-tocopherol.

Authors:  C E Myers; W McGuire; R Young
Journal:  Cancer Treat Rep       Date:  1976-07

3.  A general mechanism for microsomal activation of quinone anticancer agents to free radicals.

Authors:  N R Bachur; S L Gordon; M V Gee
Journal:  Cancer Res       Date:  1978-06       Impact factor: 12.701

4.  Adriamycin associated cardiotoxicity: research on prevention with coenzyme Q.

Authors:  C Bertazzoli; M Ghione
Journal:  Pharmacol Res Commun       Date:  1977-03

5.  Hydroxyl radical production by free and DNA-bound aminoquinone antibiotics and its role in DNA degradation. Electron spin resonance detection of hydroxyl radicals by spin trapping.

Authors:  J W Lown; S K Sim; H H Chen
Journal:  Can J Biochem       Date:  1978-11

6.  The effects of alpha-tocopherol on the toxicity, disposition, and metabolism of adriamycin in mice.

Authors:  E G Mimnaugh; Z H Siddik; R Drew; B I Sikic; T E Gram
Journal:  Toxicol Appl Pharmacol       Date:  1979-06-15       Impact factor: 4.219

7.  Antineoplastic activity and pharmacokinetics of adriamycin and daunomycin in tumor bearing mice.

Authors:  A Martini; N G Donelli; A Mantovani; M A Pacciarini; E F Fogar-Ottaviano; L Morasca; S Garattini; F S Spreafico
Journal:  Oncology       Date:  1977       Impact factor: 2.935

8.  Adriamycin analogues. 3. Synthesis of N-alkylated anthracyclines with enhanced efficacy and reduced cardiotoxicity.

Authors:  G L Tong; H Y Wu; T H Smith; D W Henry
Journal:  J Med Chem       Date:  1979-08       Impact factor: 7.446

9.  Adriamycin and daunomycin generate reactive oxygen compounds in erythrocytes.

Authors:  C A Henderson; E N Metz; S P Balcerzak; A L Sagone
Journal:  Blood       Date:  1978-11       Impact factor: 22.113

10.  Generation of superoxide anions and hydrogen peroxide from beta-lapachone in bacteria.

Authors:  F S Cruz; R Docampo; A Boveris
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.938

View more
  3 in total

Review 1.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

2.  Experimental chemotherapy-induced skin necrosis in swine. Mechanistic studies of anthracycline antibiotic toxicity and protection with a radical dimer compound.

Authors:  S D Averbuch; M Boldt; G Gaudiano; J B Stern; T H Koch; N R Bachur
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 3.  A chemical perspective on the anthracycline antitumor antibiotics.

Authors:  B R Abdella; J Fisher
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.